US 11725208
Conjugated antisense compounds and their use
granted A61KA61K31/713A61K47/554
Quick answer
US patent 11725208 (Conjugated antisense compounds and their use) held by Ionis Pharmaceuticals, Inc. expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K31/713, A61K47/554, A61K9/0085